Stock Research: Chong Kun Dang

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Chong Kun Dang

KOSE:A185750 KR7185750007
50
  • Value
    61
  • Growth
    30
  • Safety
    Safety
    46
  • Combined
    44
  • Sentiment
    73
  • 360° View
    360° View
    50
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Chong Kun Dang Pharmaceutical Corp manufactures and sells pharmaceuticals, including prescription and over-the-counter drugs, quasi-drugs, and health functional foods. The company operates in the pharmaceutical and healthcare industries, with products including antidiabetic treatments, cerebrovascular disease treatments, and OTC drugs like penzal. It sells products domestically and internationally. In the last fiscal year, the company had a market cap of $821 million, profits of $361 million, and revenue of $1074 million. The number of employees is not available.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 50 (better than 50% compared with alternatives), overall professional sentiment and financial characteristics for the stock Chong Kun Dang are above average. The 360° View is based on consolidating four consolidated indicators, with half below and half above average for Chong Kun Dang. The consolidated Sentiment Rank has a good rank of 73, which means that professional investors are more optimistic about the stock than for 73% of alternative investment opportunities. It also rates well regarding its financing structure, with the consolidated Safety Rank at 61 or better than 61% of its peers when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the stock is expensive and expects low growth. The consolidated Value Rank is only 46, meaning that the share price of Chong Kun Dang is on the high side, compared with indicators such as revenues, profits, and invested capital. The company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth,and stock returns, with its Growth Rank at 30. ...read more

more
Index
KOSPI
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
46 46 34 51
Growth
30 6 93 15
Safety
Safety
61 65 34 55
Sentiment
73 76 98 73
360° View
360° View
50 46 85 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
79 88 69 82
Opinions Change
23 26 64 50
Pro Holdings
n/a 64 80 10
Market Pulse
91 76 89 93
Sentiment
73 76 98 73
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
46 46 34 51
Growth
30 6 93 15
Safety Safety
61 65 34 55
Combined
44 49 50 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
50 51 40 51
Price vs. Earnings (P/E)
82 84 70 87
Price vs. Book (P/B)
43 43 29 39
Dividend Yield
38 34 31 32
Value
46 46 34 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
55 27 21 40
Profit Growth
14 11 89 16
Capital Growth
100 31 84 85
Stock Returns
14 26 93 5
Growth
30 6 93 15
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
47 43 31 40
Refinancing
84 80 53 71
Liquidity
41 57 45 47
Safety Safety
61 65 34 55

Similar Stocks

Discover high‑ranked alternatives to Chong Kun Dang and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Korea Investment

KOSE:A071050
Country: South Korea
Industry: Investment Banking & Brokerage
Size: Large
Full Stock Analysis

Kia Motors

KOSE:A000270
Country: South Korea
Industry: Automobile Manufacturers
Size: Large
Full Stock Analysis

Tsumura

TSE:4540
Country: Japan
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.